Nob Hill Therapeutics
Latest round
- Series A
Last raised
- Jul 2024
Total raised
- $1.8M
Investors
- 3
About Nob Hill Therapeutics
Founded in 2016, Nob Hill Therapeutics, Inc. is engaged in the development of inhalation medicines for patients with lung-related conditions. The company has not undergone any notable pivots and operates independently without known subsidiaries. The founder's background is not specified.Nob Hill Therapeutics specializes in developing innovative inhalation medicines that enhance lung delivery for patients suffering from lung diseases. The company is focused on re-envisioning delivery methods for high-dose therapies that address conditions with limited treatment options. Their products include advanced technologies designed to improve the efficiency of drug delivery directly to the lungs, thereby enhancing patient outcomes. The primary end-users are patients with respiratory ailments, as well as healthcare providers and institutions involved in respiratory care.Nob Hill Therapeutics generates revenue through partnerships and collaborations within the healthcare sector, emphasizing the development and commercialization of its inhalation technologies. The firm engages in B2B transactions with healthcare entities, research institutions, and pharmaceutical companies seeking to leverage its products in clinical settings. Revenue streams are derived from licensing agreements, joint ventures, and direct sales of proprietary inhalation systems, often structured through negotiated contracts that include milestone payments and royalties based on product performance.In August 2024, Nob Hill Therapeutics, Inc. The company aims to expand its product offerings and explore new markets. Specific future products are not detailed, but the focus remains on enhancing their inhalation technologies and potentially launching new therapies for lung diseases. The targeted markets for expansion include North America and Europe, aligning with their existing presence in these regions.
Who invested in Nob Hill Therapeutics
3 investors across 1 round
See all investors in Nob Hill Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 26, 2024
Amount
$1.8M
Investors
Questions about Nob Hill Therapeutics
Who invested in Nob Hill Therapeutics?
Nob Hill Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nob Hill Therapeutics raised?
Nob Hill Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nob Hill Therapeutics last raise money?
Nob Hill Therapeutics's most recent round on record is a Series A, in Jul 2024.
What does Nob Hill Therapeutics do?
Founded in 2016, Nob Hill Therapeutics, Inc.
Where is Nob Hill Therapeutics headquartered?
Nob Hill Therapeutics is headquartered in Albuquerque, US.
Which VCs invest in companies like Nob Hill Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nob Hill Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nob Hill Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.